Task: Answer Verification
Input (English): Question: Does irbesartan treatment influence plasma levels of the advanced glycation end products N ( epsilon ) ( 1-carboxymethyl ) lysine and N ( epsilon ) ( 1-carboxyethyl ) lysine in patients with type 2 diabetes and microalbuminuria . A randomized controlled trial?
Answer: Long-term irbesartan treatment does not influence plasma levels of the AGE CML and CEL in patients with type 2 diabetes and microalbuminuria.
Output (English): no